Skip to main content
main-content
Erschienen in: International Urogynecology Journal 5/2017

02.02.2017 | Clinical Opinion

Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence

verfasst von: Angamuthu Arunkalaivanan, Hervinder Kaur, Oseka Onuma

Erschienen in: International Urogynecology Journal | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Interest in laser therapy as a nonhormonal option for the treatment of genitourinary syndrome of menopause (GSM) has increased. We conducted a systematic review of the use of laser therapy for the relief of GSM symptoms. Six electronic databases were searched and conference abstracts were searched manually from the introduction of laser therapy to the present date. The keywords used were: “genitourinary syndrome”, “vulvovaginal atrophy”, “postmenopausal symptoms”, “laser therapy” and “fractional laser treatment”. Of the 165 articles identified in the search, none was a randomized controlled trial. As a result, we included three observational studies without a control group and one case–control study that met our inclusion criteria. The total number of women included in the four studies was 220. The collated data suggest that laser therapy may be valuable as a nonhormonal therapeutic modality in the management of GSM. Higher quality of evidence from randomized controlled trials is required to establish the efficacy of laser treatment in the management of GSM.
Literatur
1.
Zurück zum Zitat Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Maturitas. 2014;79(3):349–354. doi: 10.​1016/​j.​maturitas.​2014.​07.​013. CrossRefPubMed Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Maturitas. 2014;79(3):349–354. doi: 10.​1016/​j.​maturitas.​2014.​07.​013. CrossRefPubMed
8.
Zurück zum Zitat Gambacciani M, Torelli MG, Martella L, Bracco GL, Casagrande AG, Albertin E, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18 Suppl 1:43–48. doi: 10.​3109/​13697137.​2015.​1071608. CrossRefPubMed Gambacciani M, Torelli MG, Martella L, Bracco GL, Casagrande AG, Albertin E, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18 Suppl 1:43–48. doi: 10.​3109/​13697137.​2015.​1071608. CrossRefPubMed
10.
Zurück zum Zitat Fistonic N, Fistonic I, Lukanovic A, Findri Gustek S, Sorta Bilajac Turina I, Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18 Suppl 1:37–42. doi: 10.​3109/​13697137.​2015.​1071126. CrossRefPubMed Fistonic N, Fistonic I, Lukanovic A, Findri Gustek S, Sorta Bilajac Turina I, Franic D. First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study. Climacteric. 2015;18 Suppl 1:37–42. doi: 10.​3109/​13697137.​2015.​1071126. CrossRefPubMed
11.
Zurück zum Zitat Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–849. doi: 10.​1097/​GME.​0000000000000401​. CrossRefPubMed Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–849. doi: 10.​1097/​GME.​0000000000000401​. CrossRefPubMed
12.
Zurück zum Zitat Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429–436. doi: 10.​1007/​s10103-014-1677-2. CrossRefPubMed Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429–436. doi: 10.​1007/​s10103-014-1677-2. CrossRefPubMed
Metadaten
Titel
Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence
verfasst von
Angamuthu Arunkalaivanan
Hervinder Kaur
Oseka Onuma
Publikationsdatum
02.02.2017
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 5/2017
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-017-3282-y

Weitere Artikel der Ausgabe 5/2017

International Urogynecology Journal 5/2017 Zur Ausgabe

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Gynäkologie und bleiben Sie gut informiert – ganz bequem per eMail.